India's Indoco Remedies rises on FDA approval for anti-smoking drug

Pfizer

30/10/2024 07:19

** Shares of Indoco Remedies  INRM.NS  rise as much as 5% to
317.50 rupees
    ** Co gets U.S. FDA approval for varenicline tablets, which
are used to help quit smoking
    ** INRM last up about 2%, set to snap nine-session losing
streak
    ** Stock still down ~22% so far this year, on track for
third straight year of losses
    ** YTD, peers Pfizer Ltd  PFIZ.NS  and Ajanta Pharma
 AJPH.NS  up ~20% and ~43%, respectively

 (Reporting by Dimpal Gulwani in Bengaluru)
 ((dimpal.gulwani@thomsonreuters.com))